2-Bromo-5-propoxypyrimidine

Catalog No.: 
ACELIH710
CAS No.: 
1894032-59-7
Molecular Formula: 
C7H9BrN2O
Molecular Weight: 
217.07
2-Bromo-5-propoxypyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$109.00In stockInquiry
250mg95%$144.00In stockInquiry
500mg95%$240.00In stockInquiry
1g95%$360.00In stockInquiry
5g95%$1080.00In stockInquiry
10g95%$1691.00In stockInquiry
25g95%$3562.00InquiryInquiry
50g95%$5699.00InquiryInquiry
100g95%$9261.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-5-propoxypyrimidine
IUPAC Name2-bromo-5-propoxypyrimidine
MDL No.0
Molecular FormulaC7H9BrN2O
Molecular Weight217.07
SMILESCCCOC1=CN=C(Br)N=C1
InChI KeyWVDKBWREYHIHMP-UHFFFAOYSA-N
Synonym2-bromo-5-propoxy-pyrimidine | 1894032-59-7 | PB41540 | CS-0309561 | F78269
CAS No.1894032-59-7
PubChem CID117224640

Synthetic Route by SureRoute

1. ACELIH710 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEABI561 route compound structure diagram
    ACEABI5611240621-87-7In Stock
  4. Then
  5. ACELIH710 route product structure diagram
    ACELIH7101894032-59-7In Stock
Inquiry

2. ACELIH710 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEABI561 route compound structure diagram
    ACEABI5611240621-87-7In Stock
  4. Then
  5. ACELIH710 route product structure diagram
    ACELIH7101894032-59-7In Stock
Inquiry

3. ACELIH710 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEABI561 route compound structure diagram
    ACEABI5611240621-87-7In Stock
  4. Then
  5. ACELIH710 route product structure diagram
    ACELIH7101894032-59-7In Stock
Inquiry

Comments (0)